4//SEC Filing
Ferneau Philip 4
Accession 0001213900-20-015637
CIK 0001738021other
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 9:37 PM ET
Size
7.5 KB
Accession
0001213900-20-015637
Insider Transaction Report
Form 4
Ferneau Philip
Director
Transactions
- Purchase
Common Stock
2020-06-19$5.00/sh+250,000$1,250,000→ 400,280 total(indirect: See Footnote) - Purchase
Common Stock
2020-06-19$5.00/sh+64,066$320,330→ 2,348,976 total(indirect: See Footnote)
Footnotes (2)
- [F1]These shares are held directly by Borealis Granite Fund, L.P. Borealis Capital Partners III, LLC is the general partner of Borealis Granite Fund, L.P. The Reporting Person is a member of the board of directors, and is a managing partner of Borealis Ventures. Voting and investment decisions with respect to the securities held by Borealis Granite Fund, L.P. are made by a committee of three or more individuals, none of whom individually has the power to direct such decisions. The Reporting Person disclaims beneficial ownership of the shares held by Borealis Granite Fund, L.P., except to the extent of any actual pecuniary interest.
- [F2]These shares are held directly by Vox Health Fund, L.P. Borealis Capital Partners IV, LLC is the general partner of Vox Health Fund, L.P. Philip Ferneau, a member of the board of directors, and a managing partner of Borealis Ventures. Mr. Ferneau holds a majority ownership interest in Borealis Capital Partners IV, LLC and is the designated manager with voting and investment power over the shares held by Vox Health Fund, L.P.
Documents
Issuer
Compass Therapeutics, Inc.
CIK 0001738021
Entity typeother
Related Parties
1- filerCIK 0001814202
Filing Metadata
- Form type
- 4
- Filed
- Jun 22, 8:00 PM ET
- Accepted
- Jun 23, 9:37 PM ET
- Size
- 7.5 KB